Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities

Sandra M Lopez1, Myles C Hodgson, Charles Packianathan

  • 1Department of Cell Biology and Pharmacology, Herbert Wertheim College of Medicine, Florida International University, 11200 SW 8th St. Miami, FL 33199, USA.

Insights

The tumor suppressor INPP4B regulates cell signaling and has both lipid and protein tyrosine phosphatase (PTP) activities. Key catalytic residues were identified, revealing INPP4B regulates Akt1 phosphorylation, unlike PTEN.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • The INPP4B gene acts as a tumor suppressor, and its reduced expression correlates with poor prognoses in breast, prostate, and ovarian cancers.
  • INPP4B possesses a catalytic motif common to dual-specificity phosphatases, similar to PTEN, and has known lipid phosphatase activity.

Purpose of the Study:

  • To investigate the protein tyrosine phosphatase (PTP) activity of INPP4B.
  • To identify key amino acid residues within the INPP4B catalytic domain responsible for its phosphatase activities.
  • To determine downstream targets regulated by INPP4B.

Main Methods:

  • Enzyme assays using synthetic substrates (pNPP, DiFMUP) to assess lipid and PTP activities.
  • Site-directed mutagenesis of the INPP4B catalytic site (C842KSAKDR).
  • Western blot analysis to detect Akt1 phosphorylation levels in the presence of INPP4B and PTEN.

Main Results:

  • INPP4B demonstrated PTP activity by dephosphorylating synthetic phosphotyrosine analogs.
  • Mutagenesis studies identified specific residues critical for lipid phosphatase (K846M) and PTP (D847E) activities.
  • INPP4B, but not PTEN, reduced Akt1 tyrosine phosphorylation, indicating a unique downstream regulatory role.

Conclusions:

  • This study elucidates the dual lipid and PTP enzymatic activities of INPP4B.
  • Specific catalytic residues governing INPP4B's distinct functions were identified.
  • INPP4B regulates Akt1 phosphorylation through both lipid and PTP activities, highlighting its unique role in cellular signaling pathways.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...